Company Overview of Koronis Pharma, Inc.
Koronis Pharma, Inc. develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.
800 Fifth Avenue
Seattle, WA 98104
Founded in 1998
Key Executives for Koronis Pharma, Inc.
Similar Private Companies By Industry
|3D Biomatrix Inc.||United States|
|Harkness Pharmaceuticals, Inc.||United States|
|Innomed Healthscience, Inc.||United States|
|NeoStem Oncology, LLC||United States|
|Genesis Seed Research||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.